3 Recruiting Castration-resistant Prostate Cancer Phase 2 Clinical Trials

Active phase 2 studies for castration-resistant prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.

All Castration-resistant Prostate Cancer studies

Phase 2 Studies for Castration-resistant Prostate Cancer

🔵 Active, Not Recruiting Phase2

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

📍 Washington University Siteman Cancer Center — St Louis, Missouri

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

📍 University of California San Diego — La Jolla, California

View Study & Checklist ➔

🟢 Recruiting Phase2

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

📍 City of Hope — Duarte, California

View Study & Checklist ➔